These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 18661545)

  • 1. Elevated serotonin transporter binding in depressed patients with Parkinson's disease: a preliminary PET study with [11C]DASB.
    Boileau I; Warsh JJ; Guttman M; Saint-Cyr JA; McCluskey T; Rusjan P; Houle S; Wilson AA; Meyer JH; Kish SJ
    Mov Disord; 2008 Sep; 23(12):1776-80. PubMed ID: 18661545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered brain serotonin transporter and associated glucose metabolism in Alzheimer disease.
    Ouchi Y; Yoshikawa E; Futatsubashi M; Yagi S; Ueki T; Nakamura K
    J Nucl Med; 2009 Aug; 50(8):1260-6. PubMed ID: 19617327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated serotonin transporter binding in major depressive disorder assessed using positron emission tomography and [11C]DASB; comparison with bipolar disorder.
    Cannon DM; Ichise M; Rollis D; Klaver JM; Gandhi SK; Charney DS; Manji HK; Drevets WC
    Biol Psychiatry; 2007 Oct; 62(8):870-7. PubMed ID: 17678634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonin transporter binding in bipolar disorder assessed using [11C]DASB and positron emission tomography.
    Cannon DM; Ichise M; Fromm SJ; Nugent AC; Rollis D; Gandhi SK; Klaver JM; Charney DS; Manji HK; Drevets WC
    Biol Psychiatry; 2006 Aug; 60(3):207-17. PubMed ID: 16875929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotonergic dysregulation is linked to sleep problems in Parkinson's disease.
    Wilson H; Giordano B; Turkheimer FE; Chaudhuri KR; Politis M
    Neuroimage Clin; 2018; 18():630-637. PubMed ID: 29845011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain serotonin transporter binding in non-depressed patients with Parkinson's disease.
    Guttman M; Boileau I; Warsh J; Saint-Cyr JA; Ginovart N; McCluskey T; Houle S; Wilson A; Mundo E; Rusjan P; Meyer J; Kish SJ
    Eur J Neurol; 2007 May; 14(5):523-8. PubMed ID: 17437611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced serotonin transporter binding in the insular cortex in patients with obsessive-compulsive disorder: a [11C]DASB PET study.
    Matsumoto R; Ichise M; Ito H; Ando T; Takahashi H; Ikoma Y; Kosaka J; Arakawa R; Fujimura Y; Ota M; Takano A; Fukui K; Nakayama K; Suhara T
    Neuroimage; 2010 Jan; 49(1):121-6. PubMed ID: 19660554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantifying serotonin transporters by PET with [11C]-DASB before and after interferon-α treatment.
    Shapiro PA; Sloan RP; Deochand C; Franceschi AM; Delorenzo C; Mann JJ; Parsey RV
    Synapse; 2014 Nov; 68(11):548-55. PubMed ID: 25043294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High familial risk for mood disorder is associated with low dorsolateral prefrontal cortex serotonin transporter binding.
    Frokjaer VG; Vinberg M; Erritzoe D; Svarer C; Baaré W; Budtz-Joergensen E; Madsen K; Madsen J; Kessing LV; Knudsen GM
    Neuroimage; 2009 Jun; 46(2):360-6. PubMed ID: 19233297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preserved serotonin transporter binding in de novo Parkinson's disease: negative correlation with the dopamine transporter.
    Strecker K; Wegner F; Hesse S; Becker GA; Patt M; Meyer PM; Lobsien D; Schwarz J; Sabri O
    J Neurol; 2011 Jan; 258(1):19-26. PubMed ID: 20644949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diminished brain 5-HT transporter binding in major depression: a positron emission tomography study with [11C]DASB.
    Selvaraj S; Murthy NV; Bhagwagar Z; Bose SK; Hinz R; Grasby PM; Cowen PJ
    Psychopharmacology (Berl); 2011 Feb; 213(2-3):555-62. PubMed ID: 19756523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [¹⁸F]FDOPA uptake in the raphe nuclei complex reflects serotonin transporter availability. A combined [¹⁸F]FDOPA and [¹¹C]DASB PET study in Parkinson's disease.
    Pavese N; Simpson BS; Metta V; Ramlackhansingh A; Chaudhuri KR; Brooks DJ
    Neuroimage; 2012 Jan; 59(2):1080-4. PubMed ID: 21963917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of pallidal serotonergic function in Parkinson's disease dyskinesias: a positron emission tomography study.
    Smith R; Wu K; Hart T; Loane C; Brooks DJ; Björklund A; Odin P; Piccini P; Politis M
    Neurobiol Aging; 2015 Apr; 36(4):1736-1742. PubMed ID: 25649022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotonergic pathology and disease burden in the premotor and motor phase of A53T α-synuclein parkinsonism: a cross-sectional study.
    Wilson H; Dervenoulas G; Pagano G; Koros C; Yousaf T; Picillo M; Polychronis S; Simitsi A; Giordano B; Chappell Z; Corcoran B; Stamelou M; Gunn RN; Pellecchia MT; Rabiner EA; Barone P; Stefanis L; Politis M
    Lancet Neurol; 2019 Aug; 18(8):748-759. PubMed ID: 31229470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Vivo Evaluation of 11C-DASB for Quantitative SERT Imaging in Rats and Mice.
    Walker M; Ehrlichmann W; Stahlschmidt A; Pichler BJ; Fischer K
    J Nucl Med; 2016 Jan; 57(1):115-21. PubMed ID: 26514178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prominent role of serotonergic degeneration in apathy, anxiety and depression in de novo Parkinson's disease.
    Maillet A; Krack P; Lhommée E; Météreau E; Klinger H; Favre E; Le Bars D; Schmitt E; Bichon A; Pelissier P; Fraix V; Castrioto A; Sgambato-Faure V; Broussolle E; Tremblay L; Thobois S
    Brain; 2016 Sep; 139(Pt 9):2486-502. PubMed ID: 27538418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depressive symptoms in PD correlate with higher 5-HTT binding in raphe and limbic structures.
    Politis M; Wu K; Loane C; Turkheimer FE; Molloy S; Brooks DJ; Piccini P
    Neurology; 2010 Nov; 75(21):1920-7. PubMed ID: 21098407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolite considerations in the in vivo quantification of serotonin transporters using 11C-DASB and PET in humans.
    Parsey RV; Ojha A; Ogden RT; Erlandsson K; Kumar D; Landgrebe M; Van Heertum R; Mann JJ
    J Nucl Med; 2006 Nov; 47(11):1796-802. PubMed ID: 17079812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-HTT binding in recovered depressed patients and healthy volunteers: a positron emission tomography study with [11C]DASB.
    Bhagwagar Z; Murthy N; Selvaraj S; Hinz R; Taylor M; Fancy S; Grasby P; Cowen P
    Am J Psychiatry; 2007 Dec; 164(12):1858-65. PubMed ID: 18056241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain serotonin transporter binding potential measured with carbon 11-labeled DASB positron emission tomography: effects of major depressive episodes and severity of dysfunctional attitudes.
    Meyer JH; Houle S; Sagrati S; Carella A; Hussey DF; Ginovart N; Goulding V; Kennedy J; Wilson AA
    Arch Gen Psychiatry; 2004 Dec; 61(12):1271-9. PubMed ID: 15583118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.